Advertisement

Topics

Becker Muscular Dystrophy - Pipeline Review, H1 2015

01:13 EDT 15 Apr 2015 | BioPortfolio Reports

Recently added to the BioPortfolio report store, Becker Muscular Dystrophy - Pipeline Review, H1 2015 is a new report from Global Markets Direct published on 2015-03-10. This 39-page report is available in PDF from $2000.

Becker Muscular Dystrophy - Pipeline Review, H1 2015

Summary

Global Markets Direct’s, ‘Becker Muscular Dystrophy - Pipeline Review, H1 2015’, provides an overview of the Becker Muscular Dystrophy’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Becker Muscular Dystrophy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Becker Muscular Dystrophy and special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global therapeutic landscape of Becker Muscular Dystrophy
- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in the therapeutics development for Becker Muscular Dystrophy and enlists all their major and minor projects
- The report summarizes all the dormant and discontinued pipeline projects
- A review of the Becker Muscular Dystrophy products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- A detailed assessment of monotherapy and combination therapy pipeline projects
- Coverage of the Becker Muscular Dystrophy pipeline on the basis of target, MoA, route of administration and molecule type
- Latest news and deals relating related to pipeline products

Reasons to buy

- Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Becker Muscular Dystrophy Overview 6
Therapeutics Development 7
Pipeline Products for Becker Muscular Dystrophy - Overview 7
Pipeline Products for Becker Muscular Dystrophy - Comparative Analysis 8
Becker Muscular Dystrophy - Therapeutics under Development by Companies 9
Becker Muscular Dystrophy - Pipeline Products Glance 10
Late Stage Products 10
Clinical Stage Products 11
Early Stage Products 12
Becker Muscular Dystrophy - Products under Development by Companies 13
Becker Muscular Dystrophy - Companies Involved in Therapeutics Development 14
PTC Therapeutics, Inc. 14
ReveraGen BioPharma, Inc. 15
Sarepta Therapeutics, Inc. 16
Sphaera Pharma Pvt. Ltd. 17
Becker Muscular Dystrophy - Therapeutics Assessment 18
Assessment by Monotherapy Products 18
Assessment by Target 19
Assessment by Mechanism of Action 20
Assessment by Route of Administration 21
Assessment by Molecule Type 23
Drug Profiles 25
AAV1-Foliistatin - Drug Profile 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
Antisense Oligonucleotide to Inhibit Myostatin for DMD and Becker MD - Drug Profile 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
ataluren - Drug Profile 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
epicatechin - Drug Profile 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
Small Molecule for Becker Muscular Dystrophy - Drug Profile 31
Product Description 31
Mechanism of Action 31
R&D Progress 31
Becker Muscular Dystrophy - Recent Pipeline Updates 32
Becker Muscular Dystrophy - Dormant Projects 37
Appendix 38
Methodology 38
Coverage 38
Secondary Research 38
Primary Research 38
Expert Panel Validation 38
Contact Us 38
Disclaimer 39

For more information open Becker Muscular Dystrophy - Pipeline Review, H1 2015.

SKU: GMDHC6457IDB

Original Article: Becker Muscular Dystrophy - Pipeline Review, H1 2015

NEXT ARTICLE

More From BioPortfolio on "Becker Muscular Dystrophy - Pipeline Review, H1 2015"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Muscular Dystrophy
Muscular dystrophy is a group of degenerative inherited disorders causing muscle weakness and loss of muscle tissue. The different types are Becker muscular dystrophy, Duchenne muscular dystrophy, Emery-Dreifuss muscular dystrophy, Facioscapulohumeral mu...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...